Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 64.29 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 93.10 | Oscillator | Sell |
| Williams %R (14) | -13.36 | Oscillator | Sell |
| MACD (12, 26, 9) | 0.80 (Hist 0.55) | Oscillator | Strong Buy |
| Average Directional Index (14) | 16.49 (+DI 28.1 / -DI 13.3) | Trend | Neutral |
Current price $62.85
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| EMA 20 | 60.47 | MA | Strong Buy |
| SMA 20 | 59.71 | MA | Strong Buy |
| EMA 50 | 59.66 | MA | Strong Buy |
| SMA 50 | 60.76 | MA | Strong Buy |
| SMA 200 | 59.31 | MA | Strong Buy |
| Aug 28, 26 |
| Rosenblatt |
| maintain |
| Buy |
| Buy |
| Jul 31, 26 | Rosenblatt | maintain | Buy | Buy |
| Jun 15, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jun 11, 26 | Rosenblatt | maintain | Buy | Buy |
| Apr 27, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jan 30, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jan 30, 26 | Rosenblatt | maintain | Buy | Buy |
| Jan 26, 26 | Barrington Research | maintain | Outperform | Outperform |
| Jan 22, 26 | Rosenblatt | maintain | Buy | Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Couling John D | officer: SVP, Entertainment | M-Exempt | 7,667 @ $45.50 | $348.8K |
| Oct 1, 26 | Couling John D | officer: SVP, Entertainment | S-Sale | 6,831 @ $58.72 | $401.1K |
| Oct 1, 26 | Couling John D | officer: SVP, Entertainment | S-Sale | 836 @ $59.33 | $49.60K |
| Oct 1, 26 | Couling John D | officer: SVP, Entertainment | M-Exempt | 7,667 @ $45.50 | $348.8K |
| Oct 2, 26 | Dolby Dagmar | 10 percent owner | G-Gift | 24,108,162 | — |
| Oct 2, 26 | Dolby Dagmar | 10 percent owner | G-Gift | 24,108,162 | — |
| Sep 15, 26 | Whitten Marc | director, officer: President and CEO | A-Award | 600,000 | — |
| Sep 15, 26 | Whitten Marc | director, officer: President and CEO | A-Award | 160,256 | — |
TTM vs. 5-year historical average (annual ratios)
| Metric | DLB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 26.4x | 32.0x · sector 44.2x | Discount |
| Forward P/E (FY26E) | 14.5x | EPS est. 4.32 | Discount |
| Price / Book | 2.3x | 3.1x | Discount |
| Price / Sales | 4.3x | 5.8x | Discount |
| EV / EBITDA | 14.1x | 18.0x | Discount |
| Return on equity | 8.7% | — | Weak |
| Gross margin | 87.6% | 88.8% | In line |
| Debt / Equity | 0.02 | 0.02 | Conservative |
| Piotroski / Altman Z | 6/9 | Z 8.47 | Safe zone |
Discounted cash flow model
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year fiscal 2026 after the close of regular trading on Tuesday, November 17, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q4 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m.
Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Report) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Risk and Volatility Dolby Laboratories has a
Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation. Profitability This table compares Dolby Laboratories and Aware's net
Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even with modest revenue increases and stagnant licensing. Share repurchases—authorized up to $427 million—could alone drive EPS to levels supporting a 15x multiple and 20%+ upside.
October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3
DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, broadening its digital content footprint.
Dolby Laboratories (NYSE: DLB - Get Free Report) and Zscaler (NASDAQ: ZS - Get Free Report) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership. Institutional and Insider Ownership 58.6% of Dolby Laboratories shares
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemPR NewswireSAN FRANCISCO and MENLO PARK, Calif., Sept. 23, 2026 Across Meta AI glasses
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | 0.67 | 0.69 | Beat 2.8% | $305.0M |
| Apr 30, 2026 | 1.31 | 1.37 | Beat 4.6% | $395.6M |
| Jan 29, 2026 | 0.99 | 1.06 | Beat 6.7% | $346.7M |
| Nov 18, 2025 | 0.70 | 0.99 | Beat 41.6% | $307.0M |
| Jul 31, 2025 | 0.72 | 0.78 | Beat 8.3% | $315.5M |
| May 1, 2025 | 1.29 | 1.34 | Beat 3.9% | $369.6M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G/A | Oct 22, 2026 | 2026-10-22 13:13:51 | View |
| 4 | Oct 5, 2026 | 2026-10-05 20:42:51 | View |
| 4 | Oct 2, 2026 | 2026-10-02 18:42:54 | View |
| 4 | Sep 17, 2026 | 2026-09-17 17:08:34 | View |
| 4 | Sep 17, 2026 | 2026-09-17 17:05:35 | View |
| 4 | Sep 17, 2026 | 2026-09-17 17:03:38 | View |
| S-8 | Sep 11, 2026 | 2026-09-11 16:30:32 | View |
| 4 | Sep 3, 2026 | 2026-09-03 19:33:29 | View |
| 144 | Sep 1, 2026 | 2026-09-01 16:18:00 | View |
| 4 | Aug 28, 2026 | 2026-08-28 18:02:38 | View |
Proxy statement (DEF 14A) disclosures